Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive Basket Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Therapy in Management of Irritable Bowel Syndrome-diarrhea Predominant or Prevention of Recurrent Clostridioides Difficile Infection

NCT06948461 is registered in ClinicalTrials.gov with PharmaPlanter Technologies Inc as lead sponsor.

NCT NCT06948461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06948461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive Basket Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Therapy in Management of Irritable Bowel Syndrome-diarrhea Predominant or Prevention of Recurrent Clostridioides Difficile Infection
Lead sponsor
PharmaPlanter Technologies Inc
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
December 31, 2026
Enrollment
63 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clostridioides difficile infection, fecal microbiota therapy (fmt), irritable bowel syndrome (ibs), irritable bowel syndrome, diarrhea-predominant (ibs-d), recurrent clostridioides difficile infection (rcdi)